Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice of Extraordinary General Meeting

An Extraordinary General Meeting of Multiconsult ASA will be held on Tuesday 1 December 2020 at 16:00 CET at the Company’s main office, Nedre Skøyen vei 2, 0276 Oslo, Norway, for approval of the dividend of NOK 2.00 per share proposed by the board of directors.As a consequence of the extraordinary situation related to the corona virus the Company encourages shareholders not to attend the general meeting in person, but rather to make use of the ability to cast an advance vote or to vote by proxy. Corona measuresThe Company will hold the general meeting in such a way as to minimise the

NRC GROUP ASA – THIRD QUARTER 2020 RESULTS

Today, 10 November 2020, NRC Group has released its financial results for the third quarter of 2020. The result presentation is available on the following webcast link: https://channel.royalcast.com/nrcgroup/#!/nrcgroup/20201109_1 A Q&A session will be held at 10.00 AM (CET), and investors, analysts and journalists are welcome to participate. Participants dial-in numbers: NO: +47 2350 0296 SE: +46 (0)8 5065 3942 FI: +358 (0)9 7479 0404 DK: +45 3515 8121 UK: +44 (0)330 336 9411 US: +1 929 477 0402 Below you will find highlights and a summary from the report.

Key information relating to the cash dividend to be paid by Multiconsult ASA

Dividend amount: NOK 2.00 Declared currency: NOK Last day including right: 1 December 2020 Ex-date: 2 December 2020 Record date: 3 December 2020 Payment date: 10 December 2020 Date of approval: 1 December 2020 The dividend payment is conditioned upon approval by an extraordinary general meeting in the company, summoned to be held on 1 December 2020. See further information about the background for the dividend included in the notice for the extraordinary general meeting published on 10 November 2020. This information is published in accordance with the requirements

SEB's Nordic Outlook: COVID-19 holds the world in an iron grip

Sweden: Government and Riksbank respond with new stimulus A mixed picture is now emerging. After a surprisingly strong economic recovery in the third quarter of 2020, the second wave of the novel coronavirus is becoming significantly worse than expected. New restrictions will again lead to negative GDP growth during the fourth quarter, at the same time as stimulus measures are expanded. Because of the new overall growth curve, we are adjusting our forecast of  GDP growth in the advanced economies (the 37-country Organisation for Economic Cooperation and Development, or OECD)

Operational EBIT of DKK 103 Million for the Third Quarter of 2020

(Figures in parenthesis refer to the same period last year unless otherwise specified) The Bakkafrost Group delivered a total operating EBIT of DKK 102.7 million in Q3 2020. Total harvested volumes were 21.6 thousand tonnes gutted weight (tgw). Faroe Islands (FO): 11.1 tgw, Scotland (SCT): 10.5 tgw. The combined FO farming and VAP segments made an operational EBIT of DKK 118.4 million. The FO farming segment made an operational EBIT of DKK 96.6 million. The SCT farming segment made an operational EBIT of DKK -28.4 million. The VAP segment made an operational EBIT of DKK 21.8 million. The

Finnish startup Linear raises €1.1M to digitalize the real estate business

Linear, a company focusing on the digitalization of real estate brokerage, has closed €1.1 million in seed funding. The round was led by Innovestor Ventures (FIN), joined by institutional and private investors as well as the company’s previous backer, Superhero Capital (FIN). Linear will use the latest funding round on future growth and expansion to new markets. Linear Oy, founded in 2018, offers a digital ecosystem that is driven by artificial intelligence and machine learning to facilitate the housing trade. The services benefit both private sellers and professional realtors. Linear

Lundin Gold Reports Q3 2020 Results

VANCOUVER, November 9, 2020 /CNW/ - Lundin Gold Inc. ("Lundin Gold" or the "Company") (TSX: LUG) (Nasdaq Stockholm: LUG) is pleased to announce its results for the three and nine months ended September 30, 2020.  All amounts are in U.S. dollars unless otherwise indicated. The Company had a very strong re-start of operations at its Fruta del Norte gold mine (“Fruta del Norte”) following the temporary suspension in the second quarter due to the COVID-19 pandemic.  Fruta del Norte produced 94,250 ounces (“oz”) and sold 62,160 oz of gold, at a low cash operating cost of $632 per oz[1] sold

Norwegian Property ASA – Completes NOK 557 million private placement to fund the acquisition of Snarøyveien 30 at Fornebu

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OF AMERICA AND THE DISTRICT OF COLUMBIA) (THE "UNITED STATES"), AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Oslo, Norway, 9 November 2020: Norwegian Property ASA ("NPRO" or the "Company") has today completed a private placement with gross proceeds of NOK

Ericsson Capital Markets Day 2020

· Turn-around completed establishing a strong platform to accelerate growth and investments in 5G enterprise applications · New long-term EBITA margin target, excluding restructuring, for the Group of 15% – 18% · New long-term Free Cash flow (before M&A) target of 9% – 12% of sales · The 2022 operating margin target, excluding restructuring, of 12 – 14% remains for the Group with some adjustments between segmentsEricsson (NASDAQ: ERIC) will outline revised strategic growth ambitions and new long-term financial targets at its Capital Markets Day 2020 on November 10, 2020.

Preliminary results of the Subsequent Offering

NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE. Reference is made to the previous stock exchange notices by Solstad Offshore ASA (the "Company") pertaining to the subsequent offering of up to 1,336,973 new shares, each with a par value of NOK 1.00 (the "Offer Shares") at a subscription price of

NoHo Partners Plc’s Financial Reporting in 2021

NoHo Partners PlcSTOCK EXCHANGE RELEASE 9 November 2020 at 20:35NoHo Partners Plc’s Financial Reporting in 2021NoHo Partners Plc will publish the 2020 financial statements bulletin on Thursday 18/02/2021 approximately at 8:15am.NoHo Partners Plc’s 2020 financial statements and annual report will be published during week 11.The financial reports for 2021 will be published as follows:Interim report for January-March on Tuesday 11/05/2021 approximately at 8:15amHalf-year report for January-June on Tuesday 10/08/2021 approximately at 8:15amInterim report for January-September on

The Board of Directors of NoHo Partners Plc has resolved on a directed share issue without payment to the company’s key employees based on the share-based incentive plan

NoHo Partners PlcSTOCK EXCHANGE RELEASE 9 November 2020 at 20:30The Board of Directors of NoHo Partners Plc has resolved on a directed share issue without payment to the company’s key employees based on the share-based incentive plan The Board of Directors of NoHo Partners Plc has on 9 November 2020 resolved on a directed share issue without payment to the key employees of the company in order to pay the reward for the first earning period of the long-term share-based incentive plan from 1 December 2018 to 31 December 2019. On 3 April 2020, NoHo Partners Plc announced that the

OssDsign completes acquisition of the Scottish bone graft company Sirakoss

OssDsign AB (publ) has today completed the previously announced acquisition of Sirakoss Ltd. The transaction was announced in a press release on November 3, 2020.OssDsign has acquired all outstanding Sirakoss shares in an all-cash transaction. The purchase price of USD 11 million, not including agreed milestone and royalty payments, is divided into three cash instalments, of which the first USD 5 million payment has now been paid by OssDsign. The acquisition has been financed through the directed share issue of approximately SEK 65 million before transaction costs that OssDsign carried out

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 09.11.2020

United Bankers Corporation NOTIFICATION 09.11.2020 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 09.11.2020 Date 09.11.2020Exchange transaction BuyShare class UNIAVAmount 362Average price/share 9.2500 EURHighest price/share 9.2500 EURLowest price/share 9.2500 EURTotal price 3,348.50 EUR The shares held by United Bankers Corporation on 09.11.2020: UNIAV 26,834   On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti

EQT to sell Tia Technology to Sapiens

· EQT Mid Market to sell Tia Technology, a leading provider of insurance software solutions, to Sapiens International Corporation · During EQT’s ownership, Tia has strengthened its market position in Europe and South Africa, while accelerating its customers’ digitalization journeys  · EQT has supported significant investments in Tia’s core product, more than doubled the employee base, while broadening the product portfolio and building out its cloud capabilities EQT today announced that the EQT Mid Market fund (“EQT Mid Market”) has agreed to sell Tia Technology A/S (”Tia” or “

Updated information on extraordinary general meeting on 16 November

Reference is made to the stock exchange notice by BEWi ASA (the "Company") on 2 November 2020 regarding the notice of the extraordinary general meeting to be held on 16 November 2020 at 10:00 CET (the "EGM"). Due to the ban on all indoor events as imposed by Oslo's City Government on 6 November 2020 to decrease the spread of the coronavirus, the Company has resolved that the EGM will be held digitally. Hence, it will not be possible to attend the EGM in person. The Company will provide guidance on how to attend the EGM digitally to the shareholders who have registered attendance by

Norwegian Property ASA – Contemplated private placement of up to 49,980,000 new shares to fund the acquisition of Snarøyveien 30 at Fornebu

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OF AMERICA AND THE DISTRICT OF COLUMBIA) (THE "UNITED STATES"), AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Oslo, Norway, 9 November 2020: Norwegian Property ASA ("NPRO" or the "Company") contemplates a private placement of up to 49,980,000 new shares in

Targovax announces poster at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oslo, Norway, 9 November 2020 - Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, today announces that the poster “A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 12-month analysis of biomarkers and clinical outcomes” are now available at the Company’s website.The abstract presents the 12-month analysis of biomarkers and clinical outcome from the phase I/II trial in malignant pleural mesothelioma where ONCOS-102

Neste Corporation - Managers' Transactions, Nyberg (disposal)

Neste Corporation, Managers' Transactions, 9 November 2020 at 5.30 p.m. (EET)____________________________________________Person subject to the notification requirementName: Nyberg, CarlPosition: Other senior managerIssuer: Neste OyjLEI: 5493009GY1X8GQ66AM14Notification type: INITIAL NOTIFICATIONReference number: 5493009GY1X8GQ66AM14_20201109170401_4____________________________________________Transaction date: 2020-11-09Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009013296Nature of the transaction: DISPOSALTransaction details(1): Volume:

Peptonic to exercise loan option of 7.5 MSEK with Vidarstiftelsen

Stockholm, November 9, 2020 – Peptonic Medical AB (publ) (“Peptonic” or the “Company”) today announced that it has exercised the option to obtain a loan of 7.5 MSEK from Vidarstiftelsen according to an agreement as signed in May 2020.According to the terms of the loan agreement, the loan shall be paid out upon the Company’s request during the period 1 November 2020 to 28 February 2021. The loan is subject to an annual interest of 7 percent, to be paid in cash on a monthly basis. The loan can be converted to shares in Peptonic upon request by either of Peptonic or Vidarstiftelsen at fixed

#20-400 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Peptonic Medical files patent application for the treatment of fungal infections and bacterial vaginosis

Stockholm, November 9[th], 2020 - Peptonic Medical AB (publ) (‘Peptonic’ or ‘Company’) announces today that the Company has submitted an application for patent protection for the treatment of genital fungal infections and bacterial vaginosis with a modified VagiVital® formulation. The background to this application is i.a. positive results from in vitro studies showing an effective antifungal effect. Women suffering from fungal infections have spontaneously used VagiVital® and reported good results. In the new formulation, the properties that are judged to contribute to the positive treatment

BioStock: Xintela's CEO comments on the positive patent notice

Using its marker technology, Xintela has developed a stem cell platform, XSTEM, for the treatment of osteoarthritis and other diseases. At the end of October, Xintela announced that the European Patent Office (EPO) has issued an ”Intention to grant” for the patent application covering the company’s stem cell product XSTEM. Once the patent is approved, the stem cell product will be protected on the European market for at least another 18 years. BioStock has contacted Evy Lundgren-Åkerlund, CEO of Xintela, to find out more about XSTEM and the patent.Read the full article at biostock.se:

There are no items matching the current filter
There are no more items matching the current filter
Back to top